Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (NCT07313800) titled 'EMBRACE: Middle Meningeal Artery Embolization for Refractory Episodic Migraine' on Dec. 30, 2025.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Cortex Neurovascular
Condition:
Migraine Disorders
Refractory Migraine
Chronic Migraine
Intervention:
Procedure: Bilateral Middle Meningeal Artery Lidocaine Testing
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: March 1, 2026
Target Sample Size: 25
Countries of Recruitment:
United States
To know more, visit ...